Overview

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized, placebo-controlled, multi center trial to evaluate the efficacy and safety of levetiracetam as adjunctive treatment in adult Japanese epileptic subjects with partial onset seizures.
Phase:
Phase 2
Details
Lead Sponsor:
UCB Pharma
Collaborator:
UCB Japan Co. Ltd.
Treatments:
Etiracetam
Levetiracetam
Piracetam